AcuityMD

We’re honored to be recognized by Forbes among the world’s most promising companies shaping the future. This recognition is more than just a milestone; it’s a reflection of our team’s relentless commitment to accelerating the adoption of cutting-edge medical technologies. Every day, we partner with innovators to help breakthrough medical devices reach the patients who need them most faster, safer, and at scale. To our customers, team, and partners: thank you for believing in our mission and pushing boundaries with us. The work ahead is exciting, and we’re just getting started. Read the Article - https://hubs.li/Q03Cyvf70

AI hype won’t get your device adopted. Clinicians and administrators want evidence, ROI, and oversight. The AMA’s new AI governance toolkit is rewriting the rules for adoption, and the MedTech companies that adapt their commercial strategy will win. Our latest blog highlights the 3 strategic opportunities for MedTech teams who want to stand out in the age of AI governance. 👇 Click the link in the comments to read the full blog and learn how you can strategically address this new AMA guidance.

At AcuityMD, our product design philosophy is centered around making the most impact for our customers. That perspective shapes products that are truly supportive in the moments that matter. In our latest blog, Clarke Hyrne, Manager of Design, share how empathy drives our design process, how cross-team collaboration unlocks better solutions, and why AcuityMD is a place where designers can grow while making a real impact. 👇 Click the link in the comments to read the full blog now!

Distribution through partnerships is one of the fastest ways to scale — but only if your product and go-to-market strategy are actually partner-ready. If partnerships are on your roadmap, don't miss this Companyon Ventures Lunch and Learn panel featuring AcuityMD's Chief Product Officer, Brian Collins. This is the session to get your product AND your pipeline partner-ready.

🚀 Having the right strategy for key opinion leaders is a huge factor in successful MedTech launches. Influence and networks can be just as important as volume when targeting your early adopters, but companies often struggle to find providers who fit the bill. AcuityMD VP of Customer Experience & Co-founder Lee Smith shares how to: ✅ Quickly and easily identify the KOLs who can drive adoption ✅ Build a balanced roster across specialties, geographies, and peer networks ✅ Turn your KOL strategy into a launch advantage If a product launch is in your future, you’ll want to read this. Click the link in the comments for the full blog. 👇

We're thrilled to announce that Lance Armstrong will be joining us at Flywheel 2025! Join us for a powerful fireside chat with the endurance athlete, cancer survivor, and health and wellness investor as he reflects on his historic athletic achievements, his battle with cancer, and the innovative treatment strategy that saved his life and his cycling career. You won't want to miss his story of resilience, mental endurance, and the transformative power of personalized care. Register for Flywheel today! https://hubs.li/Q038C_QF0

🚨 Hospitals are in a hiring race, and physicians are on the move. 66% of hospitals and health systems are actively recruiting new doctors. For MedTech reps, this shift creates new opportunities but only if you act before competitors do. In our latest blog, we break down a three-step playbook that uses AcuityMD data and workflows to help you spot new physician movement, prioritize accounts, and win more business. 👇 Read the full blog in the comments.

The MedTech M&A and investment markets have heated up in 2025, but preparing for acquisition or funding is a complex process that not all startups are ready for. AcuityMD's Chief Revenue Officer, Alex Wakefield, explains in HIT Consultant how companies can position themselves to successfully take advantage of the bigger deals available this year and beyond. Read the article here - https://lnkd.in/eKUAAfF9

📉 Hospitals and health systems are rewriting their financial playbooks in 2025. 👉 Import tariffs, shifting budgets, and CMS cuts mean that proving the ROI of your technology is more important than ever. In our latest blog, we share how MedTech commercial teams can adapt their go-to-market strategy to meet the financial challenges healthcare executives need to address: ‣ Target the right accounts based on reimbursement ‣ Show how your technology reduces costly readmissions or patient leakage ‣ Unlock hidden savings in contracts 👇 Click the link in the comments to read the full blog.

Creating breakthrough medical technology is an incredible achievement. But it's only the first step on the path to acquisition or investment. In this Flywheel 2025 session, veteran MedTech commercial leaders Rob Brown and Mark Wiltshire will share how they successfully guided their respective companies to acquisition, as well as the mistakes too many MedTech startups make when going commercial. If you're planning a GTM strategy and seeing how the M&A and investment markets are heating up in MedTech, this is one session you can't miss. Click the link in the comments to register for Flywheel today!